Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LA Jolla Pharma (NQ: LJPC )

6.220 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LA Jolla Pharma

Innoviva Completes Acquisition of La Jolla Pharmaceutical
From Innoviva, Inc.
Via Business Wire
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
From Kahn Swick & Foti, LLC
Via Business Wire
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. 
Via Benzinga
Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge
U.S. stocks traded lower toward the end of trading as investors digested the recent jobs report for the month of June. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher
U.S. stocks traded lower midway through trading following the release of jobs report on Friday. 
Via Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study. 
Via Benzinga
5 Top Short Squeeze Stocks to Watch This Week
It's a new week and that means it's time to check in on all of the short squeeze stocks that traders need to keep an eye on! 
Via InvestorPlace
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News
A headline-grabbing takeover deal could be impactful for the medical community - and today, it's definitely huge news for LJPC stock holders. 
Via InvestorPlace
Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June. 
Via Benzinga
The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
LJPC Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of La Jolla Pharmaceutical Company Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal
 
Via Benzinga
Innoviva to Acquire La Jolla Pharmaceutical Company
From La Jolla Pharmaceutical Company
Via Business Wire
Recap: La Jolla Pharmaceutical Q1 Earnings
La Jolla Pharmaceutical (NASDAQ:LJPC) reported its Q1 earnings results on Monday, May 16, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
Via Benzinga
La Jolla Pharmaceutical Company Announces Share Repurchase Plan
From La Jolla Pharmaceutical Company
Via Business Wire
50 Biggest Movers From Yesterday
Gainers Krystal Biotech, Inc. (NASDAQ: KRYS) shares surged 121.7% to close at $88.24 on Monday after the company announced positive topline results from the GEM-3 Phase 3 trial... 
Via Benzinga
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company
From La Jolla Pharmaceutical Company
Via Business Wire
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate Progress
From La Jolla Pharmaceutical Company
Via Business Wire
46 Stocks Moving In Thursday's Mid-Day Session
Gainers GTT Communications, Inc. (NYSE: GTT) shares jumped 66% to $4.16 on abnormally-high volume. The company’s stock also jumped over 57% on Wednesday. Ra Medical Systems... 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Sundial Growers (NASDAQ:SNDL) shares rose 9.73% to $1.24 during Thursday's pre-market session. The company's market cap stands at $2.3 billion. La Jolla... 
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Lizhi Inc. (NASDAQ: LIZI) shares surged 57.6% to close at $6.84 on Wednesday. Flywire Corporation (NASDAQ: FLYW) gained 46.3% to settle at $35.10 after the company priced... 
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.